肝胆胰手术患者血液管理

Y. Jung, D. Choi
{"title":"肝胆胰手术患者血液管理","authors":"Y. Jung, D. Choi","doi":"10.7599/HMR.2018.38.1.56","DOIUrl":null,"url":null,"abstract":"Patients undergoing hepatobiliary and pancreatic (HBP) surgery often need to be transfused, despite advances in surgical skills and perioperative care. However, many studies have indicated that cancer patients who are transfused have higher rates of perioperative mortality and cancer recurrence, and poorer prognoses [1]. Moreover, viral or bacterial infections, immunologic reactions, and increased postoperative morbidity are other adverse consequences of allogeneic transfusions. Furthermore, since there are not enough blood donors in Korea to supply the demand, new treatment strategies for HBP patients are needed. Patient blood management (PBM) programs, medical care without allogeneic blood transfusion, have traditionally been applied in various clinical situations, e.g., when patients refuse to be transfused for religious reasons, when there is no blood to transfuse, and when safe blood is not available [2]. Although PBM is a relatively new technology in the field of HBP surgery, its general concepts are very similar to those of traditional PBM. The basic concepts of PBM applicable to the perioperative and intraoperative method have recently been described. Erythropoietin, ferritin, vitamin B12, or volume expanders and preoperative autologous blood donation (PAD) are used in perioperative PBM. Intraoperative management includes acute normovolemic hemodilution (ANH), cell salvage (Cell Saver®), and hypotensive anesthesia. Although the disadvantages of transfusion and the advantages of PBM are widely recognized, few studies have evaluated the beneficial effects of PBM in HBP surgery. Although the use of PBM in HBP operations without transfusion (including pancreaticoduodenectomy for periampullary lesions, living donor liver transplantation, and major hepatectomy) has been reported in the past few years, it is inherently challenging to carry out researches on transfusion-related issues because reasons and sequelae of transfusion are multifactorial [3-6]. The goal of this article is to review the current status of PBM programs in HBP surgery. Review","PeriodicalId":345710,"journal":{"name":"Hanyang Medical Reviews","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Patient Blood Management in Hepatobiliary and Pancreatic Surgery\",\"authors\":\"Y. Jung, D. Choi\",\"doi\":\"10.7599/HMR.2018.38.1.56\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Patients undergoing hepatobiliary and pancreatic (HBP) surgery often need to be transfused, despite advances in surgical skills and perioperative care. However, many studies have indicated that cancer patients who are transfused have higher rates of perioperative mortality and cancer recurrence, and poorer prognoses [1]. Moreover, viral or bacterial infections, immunologic reactions, and increased postoperative morbidity are other adverse consequences of allogeneic transfusions. Furthermore, since there are not enough blood donors in Korea to supply the demand, new treatment strategies for HBP patients are needed. Patient blood management (PBM) programs, medical care without allogeneic blood transfusion, have traditionally been applied in various clinical situations, e.g., when patients refuse to be transfused for religious reasons, when there is no blood to transfuse, and when safe blood is not available [2]. Although PBM is a relatively new technology in the field of HBP surgery, its general concepts are very similar to those of traditional PBM. The basic concepts of PBM applicable to the perioperative and intraoperative method have recently been described. Erythropoietin, ferritin, vitamin B12, or volume expanders and preoperative autologous blood donation (PAD) are used in perioperative PBM. Intraoperative management includes acute normovolemic hemodilution (ANH), cell salvage (Cell Saver®), and hypotensive anesthesia. Although the disadvantages of transfusion and the advantages of PBM are widely recognized, few studies have evaluated the beneficial effects of PBM in HBP surgery. Although the use of PBM in HBP operations without transfusion (including pancreaticoduodenectomy for periampullary lesions, living donor liver transplantation, and major hepatectomy) has been reported in the past few years, it is inherently challenging to carry out researches on transfusion-related issues because reasons and sequelae of transfusion are multifactorial [3-6]. The goal of this article is to review the current status of PBM programs in HBP surgery. Review\",\"PeriodicalId\":345710,\"journal\":{\"name\":\"Hanyang Medical Reviews\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hanyang Medical Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7599/HMR.2018.38.1.56\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hanyang Medical Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7599/HMR.2018.38.1.56","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

摘要

尽管手术技术和围手术期护理有所进步,但接受肝胆胰(HBP)手术的患者经常需要输血。然而,许多研究表明,接受输血的癌症患者围手术期死亡率和癌症复发率较高,预后较差[1]。此外,病毒或细菌感染、免疫反应和术后发病率增加是异体输血的其他不良后果。此外,由于国内没有足够的献血者来满足需求,因此需要新的治疗HBP患者的策略。患者血液管理(PBM)项目,即不使用同种异体输血的医疗保健,传统上应用于各种临床情况,例如,当患者因宗教原因拒绝输血时,当没有血液可输时,以及当没有安全血液时[2]。虽然PBM在高血压外科领域是一项相对较新的技术,但其一般概念与传统PBM非常相似。适用于围手术期和术中方法的PBM的基本概念最近被描述。围手术期PBM使用促红细胞生成素、铁蛋白、维生素B12或容量扩张剂和术前自体献血(PAD)。术中处理包括急性等容血液稀释(ANH)、细胞抢救(cell Saver®)和低血压麻醉。虽然输血的缺点和PBM的优点被广泛认可,但很少有研究评估PBM在高血压手术中的有益作用。虽然在过去几年已经有关于在不输血的HBP手术(包括壶腹周围病变胰十二指肠切除术、活体供肝移植和大肝切除术)中使用PBM的报道,但由于输血的原因和后遗症是多因素的,因此对输血相关问题的研究本身就具有挑战性[3-6]。本文的目的是回顾PBM项目在高血压手术中的现状。审查
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Patient Blood Management in Hepatobiliary and Pancreatic Surgery
Patients undergoing hepatobiliary and pancreatic (HBP) surgery often need to be transfused, despite advances in surgical skills and perioperative care. However, many studies have indicated that cancer patients who are transfused have higher rates of perioperative mortality and cancer recurrence, and poorer prognoses [1]. Moreover, viral or bacterial infections, immunologic reactions, and increased postoperative morbidity are other adverse consequences of allogeneic transfusions. Furthermore, since there are not enough blood donors in Korea to supply the demand, new treatment strategies for HBP patients are needed. Patient blood management (PBM) programs, medical care without allogeneic blood transfusion, have traditionally been applied in various clinical situations, e.g., when patients refuse to be transfused for religious reasons, when there is no blood to transfuse, and when safe blood is not available [2]. Although PBM is a relatively new technology in the field of HBP surgery, its general concepts are very similar to those of traditional PBM. The basic concepts of PBM applicable to the perioperative and intraoperative method have recently been described. Erythropoietin, ferritin, vitamin B12, or volume expanders and preoperative autologous blood donation (PAD) are used in perioperative PBM. Intraoperative management includes acute normovolemic hemodilution (ANH), cell salvage (Cell Saver®), and hypotensive anesthesia. Although the disadvantages of transfusion and the advantages of PBM are widely recognized, few studies have evaluated the beneficial effects of PBM in HBP surgery. Although the use of PBM in HBP operations without transfusion (including pancreaticoduodenectomy for periampullary lesions, living donor liver transplantation, and major hepatectomy) has been reported in the past few years, it is inherently challenging to carry out researches on transfusion-related issues because reasons and sequelae of transfusion are multifactorial [3-6]. The goal of this article is to review the current status of PBM programs in HBP surgery. Review
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信